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Edited by Francesc PosasAbstract Occludin is an integral-membrane protein that con-
tributes to tight junction function. We have identiﬁed casein ki-
nase Ie (CKIe) as a binding partner for the C-terminal
cytoplasmic domain of occludin by yeast two-hybrid screening.
CKIe phosphorylated occludin and co-localised and co-immuno-
precipitated with occludin from human endothelial cells. Amino
acids 265–318 of occludin were suﬃcient for CKIe binding and
phosphorylation. Deletion of the C-terminal 48 amino acids of
occludin increased CKIe binding and phosphorylation, suggest-
ing that this region inhibits CKIe binding. These data identify
CKIe as a novel occludin kinase that may be important for the
regulation of occludin.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Tight junctions are responsible for generating epithelial and
endothelial cell polarity and for the regulation of ﬂuid and ion
interchange between tissue compartments. Tight junctions are
present in both epithelial and endothelial cells and contain inte-
gral-membrane proteins from the claudin and occludin families.
Currently, 24 mammalian claudins have been identiﬁed and
these are thought to have an important role in determining para-
cellular permeability and charge selectivity [1,2]. Occludin also
localizes to tight junctions [3], although its role in regulating
tight junction function is controversial. On the one hand, it ap-
pears to regulate paracellular permeability and transepithelial
electrical resistance (TER). For example, brain endothelial cells,
which havemuch higher expression of occludin than endothelial
cells in non-neuronal tissue, have much lower permeability [4].
In addition, occludin protein and mRNA are downregulated
in some inﬂammatory bowel diseases, which correlates with en-
hanced paracellular permeability [5]. Furthermore, expression
of full length occludin in MDCK cells enhances TER [6]. On
the other hand, knockout or knockdown of occludin does not
adversely aﬀect TER or ion ﬂux through tight junctions,*Corresponding author. Fax: +44 20 7878 4040.
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doi:10.1016/j.febslet.2006.03.048although cell morphology is substantially altered [7,8] Expres-
sion of C-terminally truncated occludin increases paracellular
permeability but also increases TER [9,10], suggesting that the
occludin C-terminus has separate roles in regulating electrical
resistance and paracellular permeability.
Occludin has a short intracellular N-terminus, four mem-
brane-spanning regions linked by two extracellular loops and
a short intracellular turn, and a long cytoplasmic C-terminus.
The occludin C-terminus is predicted to adopt a coiled-coil con-
formation from Leu 440 to Glu 469 [11,12], which is involved in
many protein–occludin interactions, including the binding of
ZO-1, PKC-f, c-Yes, connexin-26, the p85 subunit of PI-3 ki-
nase and occludin itself [3]. Several occludin splice variants
have been identiﬁed, but their functions are not clear [13–15].
Occludin is extensively phosphorylated in epithelial cells
[16], and this phosphorylation correlates with its localisation
to tight junctions. Removal of calcium, resulting in junctional
disassembly, causes a decrease in occludin phosphorylation
and re-localization of the protein to the cytoplasm and/or
basolateral membrane [17]. The protein kinase(s) responsible
for the phosphorylation of occludin at tight junctions are un-
known, but it is likely that phosphorylation regulates its func-
tion. Loss of occludin tyrosine phosphorylation correlates with
decreased TER [18,19]. Tight junction reassembly and TER
recovery in MDCK epithelial cells after ATP repletion requires
tyrosine kinase activity and induces occludin phosphorylation
[18,19]. However in Xenopus embryos, dephosphorylation of
occludin coincides with tight junction formation [20]. Regula-
tion of occludin through phosphorylation may have diﬀerent
roles depending on cell type and the site of phosphorylation.
c-Yes has been shown to bind to the occludin C-terminus
and its activity is required for occludin tyrosine phosphoryla-
tion during calcium switch assays, so it is likely that this kinase
directly phosphorylates occludin, but this has not yet been
determined in vitro [12,18,21].
Occludin has been reported to be a target for phosphoryla-
tion on serine and threonine residues by PKC [17], CK2
[22,23] and p34cdc2/cyclin B [20]. In Xenopus laevis, Ser379 and
Thr375 in the C-terminal cytoplasmic domain of occludin have
been identiﬁed as in vitro targets for CK2 [22]. PKC phosphor-
ylates occludin Ser338 in vitro and activation of PKCwith phor-
bol esters induces occludin phosphorylation and recruitment to
sites of cell–cell contact in MDCK cells [17]. However, PKC
activation has also been reported to induce occludin Thr
dephosphorylation, correlating with increased paracellular per-
meability in LLP-CK1 epithelial cells [24].blished by Elsevier B.V. All rights reserved.
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binding protein. CKIe and the closely related CK1a bind to
the occludin C-terminal domain in GST-pull down experi-
ments. CKIe co-localises and co-immunoprecipitates with
occludin from endothelial cell lysates, and it phosphorylates
occludin in in vitro kinase assays. Moreover, truncation of
the extreme occludin C-terminus increases CKIe association
and occludin phosphorylation. These data identify CKIe as a
potentially important protein in the phosphorylation and reg-
ulation of the tight junction protein occludin.2. Materials and methods
2.1. Cell culture
Pooled human umbilical vein endothelial cells (HUVECs) were ob-
tained and cultured in EBM-2 medium (Cambrex-Biowhittaker), sup-
plemented with 3% fetal calf serum (FCS) and growth factors (EGM-2
SingleQuots, Cambrex-Biowhittaker). Cells were plated on ﬂasks, ﬁl-
ters or glass coverslips that had been previously coated with 10 lg/
ml human ﬁbronectin (Sigma–Aldrich).
2.2. Yeast two-hybrid screen
The Clontech Matchmaker GAL4 Two-Hybrid System 3 was used
according to the manufacturer’s instructions. The entire occludin C-
terminal cytoplasmic region (cOcc: V265–T522) was ampliﬁed from
pBluescript II vector containing full length human occludin cDNA
(a kind gift from Dr. Christina Van Itallie) by PCR using the following
primers (MWG):
5 0 cOcc: 5 0-CGG AAT TCG TGA AAA CTC GAA GAA AGA TG-
3 0;
3 0 cOcc: 5 0-CGG GAT CCC TAT GTT TTC TGT CTA TCA TAG-3 0
The PCR product was cloned into pGBT9 to encode a fusion protein
of the GAL4-DNA binding domain and cOcc (as bait). A Human Lung
Matchmaker cDNA library in pACT2 (Clontech), which produces pro-
teins fused to the GAL4-activation domain, was used to screen for pro-
teins that interact with cOcc. The initial screen was conducted in HF7c
yeast. Bait and library plasmids were co-transformed into HF7c yeast
and yeast transformants that were positive for an interaction between
cOcc and a library protein were selected on medium lacking histidine,
tryptophan and leucine. True interactions were selected from these col-
onies by a b-galactosidase colony-lift ﬁlter assay (Clontech Yeast Pro-
tocols Handbook PT3024-1). These interactions were veriﬁed in a
separate yeast strain, SFY526. pACT2 clones were puriﬁed from
HF7c and transformed into SFY526 yeast either alone or in combina-
tion with pGBT9-cOcc. Single and double transformants were then
used in a colony-lift ﬁlter assay as well as a chlorophenol red-b-D-galac-
topyranoside (CPRG) colour change assay (Clontech Yeast Protocols
Handbook PT3024-1). pACT2-cDNAs that produced a colour with
pGBT9-cOcc in these assays were puriﬁed and sequenced. The library
cDNA was identiﬁed using the BLAST search engine.
2.3. Construction of GST-cOcc and GST-cOcc deletion mutants
The cytoplasmic C-terminal region of occludin, cOcc (V265–T522),
cOcc truncation mutants, cOccD1, cOccD2, cOccD3 and cOccD4, and
the cytoplasmic N-terminal region of occludin, nOcc (S2-P61) were
ampliﬁed from pBluescript II-occludin using the following primers
(MWG), and were cloned into pGEX-2T to produce GST fusion pro-
teins.
5 0 primers:
cOcc, CGGGATCCGTGAAAACTCGAAGAAAGATG
nOcc, CGGGATCCTCATCCAGGCCTCTTGAAAG
3 0 primers:
cOcc (V265–T522), CGGAATTCCTATGTTTTCTGTCTATCA-
TAG;
cOccD1 (V265–Y474), CGGAATTCC TAGTACTCTTCACTTTC-
TTCTC;
cOccD2 (V265–L411), CGGAATTCCTACAGCT CATCACAGG-
ACTC;
cOccD3 (V265–R367), CGGAATTCCTAACGAGGCTGCCT GAA-
GTC;cOccD4 (V265–R318), CGGAATTCCTATCTTTCCACATAGTCA
GATG.
nOcc, CGGGATCCCTAAGGAGAGGTCCATTTGTAG Proteins
were expressed in E. coli, the cells were lysed (50 mM Tris–HCl pH 7.5,
50 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 1 mM PMSF) and pro-
tein puriﬁed with glutathione sepharose (GS) beads (Amersham Biosci-
ence).
2.4. GST pull-down experiments
Approximately 20 lg of recombinant GST-cOcc protein was used
per pull-down. Conﬂuent HUVECs were starved for 2 h in 1% FCS
in EBM-2 basal medium lacking growth factors (Cambrex-Biowhit-
taker) and lysed in 1% Triton-X-100 lysis buﬀer (1% Triton X-100;
10 mM HEPES, pH 7.5; 1 mM MgCl2; 150 mM KCl; 1 mM phen-
ylmethanesulfonyl ﬂuoride; 1 mM DTT; and 10 lg/ml leupeptin) and
the lysates rotated for 30 min at 4 C. Lysates were cleared by centri-
fugation at 13000 · g for 30 min and the supernatants incubated with
GST-cOcc or the GST-cOcc deletion mutants for 1 h at 4 C with rota-
tion. The beads were washed three times with lysis buﬀer and boiled in
Laemmli sample buﬀer prior to analysis by SDS–PAGE and Western
blotting using a mouse monoclonal anti-CKIe antibody (BD Trans-
duction Laboratories) or a goat polyclonal anti-CKIa antibody (Santa
Cruz Biotechnology). Gels were stained with Coomassie blue to visu-
alize protein bands.
2.5. Cos7 cell electroporation, immunoprecipitations and CKIe
puriﬁcation
Expression vectors (pCS2) encoding human CKIe and kinase-dead
CKIe were a kind gift from Dr. David Virshup. CKIe and kinase-dead
CKIe were expressed and puriﬁed from Cos7 cells. Cos7 cells were
grown in Dulbecco’s modiﬁed Eagles medium containing 10% bovine
fetal calf serum and penicillin/streptomycin (Invitrogen). DNA (5 lg)
was transfected by electroporation in 250 ll of cold electroporation
buﬀer (120 mM KCl; 10 mM K2PO4/KH2PO4, pH 7.6; 25 mM
HEPES, pH 7.6; 2 mMMgCl2 and 0.5% Ficoll). The cells were electro-
porated in 0.4 cm Gene Pulser Cuvettes (Bio Rad) at 250 V and 960 lF
and the cells grown in full medium for 24 h. For CKIe puriﬁcation, the
cells were lysed in immunoprecipitation buﬀer (1% Triton-X-100,
20 mM Tris–HCl, pH 8, 130 mM NaCl, 10 mM sodium ﬂuoride, 1%
aprotinin, 10 lg/ml leupeptin, 1 mM DTT, 0.1 mM sodium orthovan-
adate, and 1 mM phenylmethanesulfonyl ﬂuoride) and protein immu-
noprecipitated with 2 lg mouse monoclonal CKIe antibody (BD
Transduction Laboratories) coupled to protein G sepharose (Amer-
sham Bioscience). The puriﬁed CKIe was subjected to a high salt wash
(0.5 M NaCl) to remove co-precipitating proteins.
For co-immunoprecipitation of occludin with CKIe, conﬂuent HU-
VECs were starved for 2 h in 1% FCS, lysed in immunoprecipitation
buﬀer and CKIe was immunoprecipitated as above. Immunoprecipi-
tates were washed with immunoprecipitation buﬀer, resolved by
SDS–PAGE and immunoblotted with rabbit anti-occludin antibody
(Zymed).
2.6. In vitro kinase assays
Puriﬁed CKIe, kinase-dead CKIe and 3 lg/ml phosvitin (Sigma)
were dephosphorylated in dephosphorylation buﬀer (50 mM Tris–
HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 1 mM MnCl2) containing
0.025 U PP1C (NEB) for 30 min at 37 C. Reactions were stopped
with 250 U of protein phosphatase inhibitor-2 (NEB). Kinases were
washed and 0.1 lCi/ul 32P-c-adenosine 5 0-triphosphate (ATP)
(Amersham Bioscience) was added in kinase buﬀer (50 mM Tris–
HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, and 30 lM ATP). Sub-
strate was added (0.1 lg of the dephosphorylated phosvitin or 1
or 20 lg GST, GST-cOcc or GST-nOcc fusion proteins), and reac-
tions incubated at 37 C for 30 min. Samples were boiled in Lae-
mmli sample buﬀer and resolved by SDS–PAGE. Gels were
stained with Coomassie blue, dried and protein phosphorylation de-
tected by autoradiography.
2.7. Immunoﬂuorescence
HUVECs were pre-extracted in 0.2% Triton buﬀer (0.2% Triton-X-
100, 100 mM KCl, 3 mM MgCl2, 1 mM CaCl2, 300 mM sucrose, and
10 mMHEPES) for 30 s on ice. Cells were washed twice in PBS lacking
calcium and magnesium and ﬁxed in 3.7% paraformaldehyde for
20 min. Cells were permeabilised in 0.1% SDS and 0.1% Triton-X-
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and incubated with rabbit occludin antibody (Zymed) overnight at
4 C. Cells were incubated with mouse CKIe antibody (BD Transduc-
tion Laboratories) for 2 h at room temperature, then with FITC-con-
jugated rabbit and Cy5-conjugated mouse secondary antibodies
(Jackson ImmunoResearch) for 1 h. Specimens were mounted in Mow-
iol (Merck Bioscience) and images taken using a Zeiss LSM 510 con-
focal microscope.3. Results
3.1. Identiﬁcation of CKIe as an occludin binding partner in a
yeast two-hybrid screen
The entire C-terminal cytoplasmic tail of human occludin
(cOcc) (Val265–Thr522) was used in a yeast two-hybrid screen
with human lung library cDNA to identify novel binding part-
ners for occludin. This region encompasses the 29-amino acid
predicted coiled-coil domain (Leu440–Glu469) and surround-
ing regions (Fig. 1D). Initial screening in HF7c yeast produced
nine interacting clones, three of which were analysed in more
detail (designated C1, F1 and H2, Fig. 1A). The interactions
between these clones and cOcc were veriﬁed using a diﬀerent
yeast strain (Fig. 1A and B). The inserts in C1, F1 and H2 were
sequenced and found to encode regions of SKI-interacting pro-
tein (C1), casein kinase 1e (CK1e; F1) and Unc-51-like kinase
(H2) (Fig. 1C). The region of CK1e present in clone F1 encom-Fig. 1. Identiﬁcation of human proteins that bind to the C-terminal cytoplas
pGBT9-cOcc and pACT2-F1, pACT2-C1 or pACT2-H2 survive on selecti
produced b-galactosidase resulting in a blue colour change in HF7c yeast Co
pACT2-F1, pACT2-C1 or pACT2-H2 produced b-galactosidase and a col
galactosidase when singly transformed with either cOcc or F1 cDNA. Binding
of b-galactosidase and a colour change in Colony-Lift assays. (C) Library cD
engine. The NCBI accession numbers are shown. (D) Schematic representatio
used in the yeast two-hybrid screen is diagonally stripped and encompassed t
stripes are the putative integral membrane domains. For CKIe, the dotted
which lies within the kinase domain (grey shading).passed amino acids 85–109, within the kinase domain
(Fig. 1D). This interaction between cOcc and CK1e was stud-
ied further.
3.2. Occludin associates and co-localizes with CKIe in
endothelial cells
In order to conﬁrm the interaction between cOcc and CKIe,
GST pull-down experiments were performed. GST-cOcc was
incubated with human umbilical vein endothelial cell (HU-
VEC) lysates, associating proteins were separated by SDS–
PAGE and CKIe was identiﬁed by Western blotting using an
antibody speciﬁc to this CKI isoform (Fig. 2). Two bands were
detected by the CKIe antibody in HUVEC lysates, which may
represent diﬀerent CKIe isoforms or a degradation product of
CKIe. Of these two bands, only the slower migrating band
bound to GST-cOcc. A similar fusion protein for the N-termi-
nal cytoplasmic domain of occludin, GST-nOcc, did not bind
CKIe (data not shown), indicating that the interaction is spe-
ciﬁc for the C-terminal domain. The region of CKIe that
bound to cOcc in the yeast 2-hybrid screen is within the kinase
domain (Fig. 1D) and is highly conserved in other CKI
isoforms [25]. We therefore tested whether a closely related iso-
form, CKIa, which is present in HUVECs (Fig. 2), could inter-
act with cOcc. GST-cOcc was able to pull-down CKIa from
HUVEC lysates (Fig. 2), as predicted based on the sequence
homology between CKIa and CKIe.mic domain of occludin in yeast. (A) HF7c yeast co-transformed with
on plates lacking tryptophan, leucine and histidine. These yeast also
lony-Lift assays. SFY526 yeast co-transformed with pGBT9-cOcc and
our change in CRPG assays. (B) SFY526 yeast cannot produce a b-
of F1 to cOcc in co-transformed SFY526 yeast enabled the production
NAs encoding F1, C1 and H2 were identiﬁed using the BLAST search
n of human occludin and human CKIe proteins. The region of occludin
he predicted coiled-coiled domain (black shading). The horizontal grey
region is the area identiﬁed in the yeast two-hybrid screen (clone F1),
Fig. 2. CKIe in endothelial cells binds to the C-terminal cytoplasmic
domain of occludin. Conﬂuent HUVECs were starved for 2 h in 1%
FCS and lysed in 1% Triton-X-100 lysis buﬀer prior to incubation with
GST or GST-cOcc on glutathione beads. Beads were washed,
associating proteins were separated by SDS–PAGE and CKIe was
detected by Western blotting using a mouse monoclonal CKIe
antibody (upper panel). The gel was stained with Coomassie blue to
show equivalent protein loading in each lane. Similarly, CKIa was
detected using a goat polyclonal CKIa antibody (lower panel). WCL,
whole cell lysate.
Fig. 4. Occludin and CKIe co-localise at cell–cell borders in endothe-
lial cells. HUVECs were grown until conﬂuent on ﬁbronectin-coated
glass coverslips and starved for 2 h in 1% FCS. Cells were pre-
extracted in 0.2% Triton-X-100 extraction buﬀer prior to ﬁxation and
permeabilisation. Cells were stained with antibodies to occludin and
CKIe and examined using confocal microscopy. An example of CKIe
localization to cell junctions is indicated by a white arrow.
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VECs (Fig. 3), indicating that the proteins interact in vivo.
Occludin is localizes to tight junctions in endothelial cells
[26]. In order to test whether endogenous CKIe co-localizes
with occludin, HUVECs were co-stained with antibodies to
occludin and CKIe. Both occludin and CKIe were detected
at cell borders with a similar staining pattern, indicative of
co-localization (Fig. 4). In contrast, proteins known to localizeFig. 3. Endogenous occludin and CKIe co-immunoprecipitate. Con-
ﬂuent HUVECs were starved for 2 h in 1% FCS, lysed in 1% Triton-X-
100 lysis buﬀer and CKIe was immunoprecipitated using a mouse
monoclonal antibody. A mouse monoclonal c-myc antibody was used
as a negative control. Co-precipitating proteins were separated by
SDS–PAGE and occludin was detected by western blotting using a
rabbit polyclonal antibody. WCL, whole cell lysate.to endothelial adherens junctions, such as VE-cadherin and b-
catenin (data not shown; see [27]), show a very diﬀerent stain-
ing pattern to occludin, and thus it is unlikely that CKIe asso-
ciates with adherens junctions. CKIe was also localized in the
nucleus as well as a discrete perinuclear region, suggestive of
Golgi localisation.
3.3. C-terminal truncation of cOcc increases its association with
CKIe
In order to determine the region of cOcc that interacts with
CKIe, a series of truncation mutants (cOccD1–4) were ex-
pressed as GST-fusion proteins for use in pull-down experi-
ments. CKI has been reported to phosphorylate Ser or Thr
residues within the consensus sequence, S(p)/T(p)-X2–3-S/T-X
although it also phosphorylates other non-canonical sequences
[25]. The occludin C-terminus contains seven consensus se-
quence sites for CKI phosphorylation, and thus the truncations
were engineered between these sites (Fig. 5A). This region does
not contain any known non-canonical CKI phosphorylation
sites [28]. GST-cOccD1–4 were incubated with HUVEC lysates.
CKIe associated with all of the deletion mutants, including
cOccD4, which contains just two of the CKI phosphorylation
consensus sequences and 54 juxta-membrane amino acids
(Fig. 5B and C). Interestingly, CKIe exhibited greater binding
to cOccD1 than to full length cOcc (Fig. 5B), which suggests
that the C-terminal region (48 amino acids; M475–T522) inhib-
its CKIe binding. cOccD1 bound more CKIe than cOccD2–4,
suggesting that two regions of occludin contribute to CKIe
binding: one including amino acids 411–474 (not present in
cOccD2–4) and the other 265–318, which is the membrane-
proximal region present membrane in all truncation mutants.
3.4. CKIe phosphorylates cOcc
To test whether CKIe can phosphorylate occludin, GST-
cOcc was used in in vitro kinase assays with puriﬁed recombi-
nant human CKIe or a kinase-dead CKIemutant, containing a
Lys to Ala mutation at amino acid 38 (K38A), which has been
previously reported to lack kinase activity [29]. The egg yolk
protein phosvitin (34 kDa) is a known target for CKIe phos-
phorylation [30] and was used as a positive control. Autoradi-
ography revealed a heavily phosphorylated protein band of
42 kDa in all lanes containing wild-type CKIe, which is the
predicted size of CKIe and is indicative of autophosphoryla-
tion of the kinase as previously reported [31] (Fig. 6A).
Wild-type CKIe phosphorylated the 60 kDa GST-cOcc and
phosvitin but not GST (Fig. 6A). This phosphorylation was
Fig. 5. CKIe associates with truncation mutants of cOcc. (A) Four
truncation mutants of cOcc were designed to remove sequentially the
CKIe phosphorylation consensus sequences (S(p)/T(p)-X2–3-S/T-X)
(underlined). Bold letters indicate the occludin coiled-coil domain. (B)
Conﬂuent HUVECs were lysed in 1% Triton-X-100 buﬀer and
incubated with puriﬁed recombinant GST-tagged cOcc deletion
mutants or GST for 1 h. Associating proteins were separated by
SDS–PAGE and CKIe was detected by Western blotting. The gel was
stained with Coomassie blue to show protein loading in each lane.
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kinase-dead CKIe was used, conﬁrming that the phosphoryla-
tion was performed by CKIe and not by contaminating ki-
nases. GST-nOcc was not phosphorylated by CKIe,
consistent with its inability to bind to CKIe (data not shown).
These data show that CKIe can phosphorylate the C-terminal
but not N-terminal cytoplasmic domain of occludin.
3.5. CKIe phosphorylates cOcc deletion mutants
As the GST pull-down experiments indicated that CKIe is
able to bind to the shortest occludin truncation mutant,
cOccD4 (Fig. 4), we investigated whether this, and the other
deletion mutants, are also targets for phosphorylation by
CKIe. In vitro kinase assays were carried out using GST-
cOccD1–4. Consistent with the results from the pull-down
experiments, cOccD1 was a better substrate for CKIe com-
pared with cOcc (Fig. 6B). Removal of the C-terminal 48 ami-
no acids of cOcc therefore enhances both CKIe binding and
phosphorylation of occludin. The deletion mutants cOccD2–4were also phosphorylated, but to a lesser extent than either
cOcc or cOccD 1. It is therefore likely that CKIe phosphory-
lates multiple sites on cOcc in vitro, including at least one of
the two sites present in cOccD4 (Fig. 6A).4. Discussion
We have shown here that the tight junction protein occludin
associates with a casein kinase I isoform, CKIe. In human
endothelial cells, endogenous occludin and CKIe co-localise
at cell-cell borders and co-immunoprecipitate. This suggests
a link between CKIe and tight junctions, similar to that pro-
posed for CKId and gap junctions [37].
The present study demonstrates that occludin is a substrate
for phosphorylation by CKIe. Xenopus laevis occludin has pre-
viously been reported to be a weak substrate for CKI puriﬁed
from rat liver [22], but the CKI isoforms present were not
known. The C-terminus of Xenopus laevis occludin has 48%
identity with human occludin, and contains ﬁve CKI consen-
sus sequences compared to the seven present in the C-terminus
of human occludin. However, since CKIe rapidly autophos-
phorylates and inactivates itself in vitro, it is important to
de-phosphorylate CKIe prior to kinase assays in order to acti-
vate the enzyme [31]. This may explain why only weak phos-
phorylation was observed previously. The region of CKIe
identiﬁed to bind to occludin in our yeast two-hybrid screen
is within the kinase domain, consistent with occludin being a
substrate of CKIe. This region is highly conserved in other
CKI isoforms, and indeed we ﬁnd that CKIa can also bind
to the C-terminal domain of occludin. Whether other CKI iso-
forms in addition to CKIe interact or co-localize with occludin
in cells remains to be established.
Interestingly, removal of the C-terminal 48 amino acids of
occludin results in increased binding and phosphorylation by
CKIe. This indicates that this region inhibits the association
with CKIe and suggests that relief of this inhibition may be re-
quired in cells to allow CKIe access to its target residues on
occludin. Other groups have reported changes in occludin func-
tion as a result of C-terminal truncations. In Xenopus embryos,
over-expression of chicken occludin lacking the C-terminus re-
sults in loss of intercellular barrier function, although its local-
ization to junctions is unchanged [10]. Other studies have
demonstrated the importance of the occludin C-terminus in
localising occludin to the basolateral membrane and to tight
junctions, as well as in mediating endocytosis and regulating
paracellular permeability, TER and intramembrane diﬀusion
[3,9]. It is possible that cleavage of occludin, or a conforma-
tional change, facilitates the binding of proteins such as CKIe,
and could be an important mechanism for the regulation of
occludin function. Given the multiple protein–protein interac-
tions described for the C-terminus of occludin [3], it is likely
that C-terminal phosphorylation regulates the assembly and
composition of occludin-containing protein complexes.
CKIe has previously been shown to be activated by increased
intracellular calcium [32]. Calcium-dependent stimulation of
protein phosphatase 2B (calcineurin) results in dephosphoryla-
tion of residues near the C-terminus of CKIe, leading to its acti-
vation. A similar mechanism of activation may be required for
CKIe-mediated phosphorylation of occludin. Several stimuli
are known to increase intracellular calcium and aﬀect tight junc-
tion permeability in endothelial cells, such as lysophosphatidic
Fig. 6. CKIe phosphorylates occludin in vitro. (A) In vitro kinase assays were performed on GST or on GST-cOcc using puriﬁed, recombinant wild-
type or kinase-dead CKIe, or in the absence of kinase as a negative control. Wild-type (WT) and kinase-dead (KD) CKIe were incubated with PP1A,
which activates CKIe. PP1A was subsequently inactivated by protein phosphatase inhibitor 2 (I-2), then CKIe was incubated with substrate in the
presence of 32P-c-ATP. Phosvitin was used as a positive control substrate. (B) In vitro kinase assays were performed on GST or on GST-cOcc
deletion mutants using wild type CKIe. CKIe was de-phosphorylated prior to the kinase assay. Proteins were separated by SDS–PAGE and
visualized by Coomassie blue staining. Phosphorylation was detected by autoradiography and the presence of WT and KD CKIe was veriﬁed by
immunoblotting. Arrowheads indicate phosphorylated occludin; arrows show autophosphorylated CKIe.
J.A.G. McKenzie et al. / FEBS Letters 580 (2006) 2388–2394 2393acid (LPA) [33], thrombin and histamine [34]. LPA and hista-
mine have been shown to alter occludinmobility in SDS–PAGE,
which was attributed to Ser/Thr phosphorylation [35]. LPA-in-
duced phosphorylation of occludin in ECV304 cells involves
Rho/ROCK pathways, as inhibition of either of these proteins
reduced occludin phosphorylation and LPA-induced perme-
ability. However, the kinase(s) responsible for occludin phos-
phorylation downstream of histamine in endothelial cells
remains undetermined, and in the future it will be interesting
to determine whether CKIe has a role in this pathway and
whether CKIe phosphorylates occludin in vivo.
In conclusion, phosphorylation of occludin is well established
to correlate with its localization and function at tight junctions
[3,16,36], yet signaling pathways mediating occludin phosphor-
ylation have not been elucidated. We report here a novel associ-
ation between CKIe and occludin, and hypothesise that CKIe
plays a role in regulating occludin function at tight junctions.Acknowledgements:We thankChristinaVan Itallie for the humanocclu-
din cDNA and David Virshup for providing the CKIe constructs. This
research was supported by the Ludwig Institute for Cancer Research
and EU Project Nos. QLG1-1999-01036 and FP6-502935 (MAIN).References
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